tiprankstipranks
Amgen to present Tezspire Phase 2a COPD data at ATS 2024
PremiumThe FlyAmgen to present Tezspire Phase 2a COPD data at ATS 2024
15d ago
Amgen price target lowered to $360 from $370 at TD Cowen
PremiumThe Fly
Amgen price target lowered to $360 from $370 at TD Cowen
17d ago
Early notable gainers among liquid option names on April 11th
PremiumThe Fly
Early notable gainers among liquid option names on April 11th
20d ago
Amgen opens state-of-the-art biomanufacturing facility in central Ohio
PremiumThe FlyAmgen opens state-of-the-art biomanufacturing facility in central Ohio
2M ago
Amgen to host conference call
PremiumThe Fly
Amgen to host conference call
2M ago
Amgen to host conference call
PremiumThe Fly
Amgen to host conference call
2M ago
Amgen price target raised to $380 from $350 at Oppenheimer
PremiumThe FlyAmgen price target raised to $380 from $350 at Oppenheimer
3M ago
Amgen downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Amgen downgraded to Market Perform from Outperform at Leerink
3M ago
Amgen sees more than a dozen significant pipeline milestones in 2024
PremiumThe Fly
Amgen sees more than a dozen significant pipeline milestones in 2024
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100